Plasma and cerebrospinal fluid pharmacokinetics of moxifloxacin in a patient with tuberculous meningitis

Antimicrob Agents Chemother. 2008 Jun;52(6):2293-5. doi: 10.1128/AAC.01637-07. Epub 2008 Mar 24.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anti-Bacterial Agents* / administration & dosage
  • Anti-Bacterial Agents* / cerebrospinal fluid
  • Anti-Bacterial Agents* / pharmacokinetics
  • Area Under Curve
  • Aza Compounds / administration & dosage
  • Aza Compounds / cerebrospinal fluid
  • Aza Compounds / pharmacokinetics
  • Drug Monitoring
  • Fluoroquinolones
  • Humans
  • Male
  • Moxifloxacin
  • Quinolines / administration & dosage
  • Quinolines / cerebrospinal fluid
  • Quinolines / pharmacokinetics
  • Tuberculosis, Meningeal / blood
  • Tuberculosis, Meningeal / cerebrospinal fluid
  • Tuberculosis, Meningeal / drug therapy*

Substances

  • Anti-Bacterial Agents
  • Aza Compounds
  • Fluoroquinolones
  • Quinolines
  • Moxifloxacin